A device used in cardiac surgery and a powered-arm prosthesis will both be regulated as moderate-risk, class II devices, US FDA affirmed in a pair of Oct. 17 Federal Register notices.
Both classifications stem from new device types that were previously cleared for market via the de novo process. Manufacturers of...